Literature DB >> 28748775

Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa.

J C Hoogendoorn1, L Ranoto1, N Muditambi1, J Railton1, M Maswanganyi2, H E Struthers1, J A McIntyre1, R P H Peters1.   

Abstract

Scale-up of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection has reduced the incidence of pulmonary tuberculosis (PTB) in South Africa. Despite the strong association of HIV infection with extrapulmonary tuberculosis (EPTB), the effect of ART on the epidemiology of EPTB remains undocumented. We conducted a retrospective record review of patients initiated on treatment for EPTB in 2009 (ART coverage <5%) and 2013 (ART coverage 41%) at four public hospitals in rural Mopani District, South Africa. Data were obtained from TB registers and patients' clinical records. There was a 13% decrease in overall number of TB cases, which was similar for cases registered as EPTB (n = 399 in 2009 vs. 336 in 2013; P < 0·01) and for PTB (1031 vs. 896; P < 0·01). Among EPTB cases, the proportion of miliary TB and disseminated TB decreased significantly (both P < 0·01), TB meningitis and TB of bones increased significantly (P < 0·01 and P = 0·02, respectively) and TB pleural effusion and lymphadenopathy remained the same. This study shows a reduction of EPTB cases that is similar to that of PTB in the context of the ART scale-up. The changing profile of EPTB warrants attention of healthcare workers.

Entities:  

Keywords:  Antiretroviral therapy; extrapulmonary tuberculosis; human immunodeficiency virus; pulmonary tuberculosis; rural South Africa

Mesh:

Substances:

Year:  2017        PMID: 28748775      PMCID: PMC9148802          DOI: 10.1017/S095026881700156X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  38 in total

1.  Site of extrapulmonary tuberculosis is associated with HIV infection.

Authors:  Ira L Leeds; Matthew J Magee; Ekaterina V Kurbatova; Carlos del Rio; Henry M Blumberg; Michael K Leonard; Colleen S Kraft
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

2.  Changes in the incidence and management of spinal tuberculosis in a French university hospital rheumatology department from 1966 to 2010.

Authors:  Cécile Wibaux; Marlyse Moafo-Tiatsop; Irina Andrei; Emmanuel Biver; Anne Cotten; Bernard Cortet; Bernard Duquesnoy; René-Marc Flipo
Journal:  Joint Bone Spine       Date:  2012-11-20       Impact factor: 4.929

3.  Clinical outcomes and mortality associated factors in patients infected with HIV receiving a presumptive anti-tuberculosis treatment in a tertiary level hospital in Burkina Faso.

Authors:  Eric Arnaud Diendéré; Gisele Badoum; René Bognounou; Oumar Guira; Leonce Ilboudo; Herve Tieno; Ismael Diallo; Joseph Drabo
Journal:  AIDS Care       Date:  2015-08-20

4.  Extrapulmonary tuberculosis: epidemiology and risk factors.

Authors:  José Francisco García-Rodríguez; Hortensia Álvarez-Díaz; María Virginia Lorenzo-García; Ana Mariño-Callejo; Álvaro Fernández-Rial; Pascual Sesma-Sánchez
Journal:  Enferm Infecc Microbiol Clin       Date:  2011-05-12       Impact factor: 1.731

5.  Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis.

Authors:  Ananta Nanoo; Alane Izu; Nazir A Ismail; Chikwe Ihekweazu; Ibrahim Abubakar; David Mametja; Shabir A Madhi
Journal:  Lancet Infect Dis       Date:  2015-06-22       Impact factor: 25.071

6.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Authors:  Motasim Badri; Douglas Wilson; Robin Wood
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

Review 7.  Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis.

Authors:  Cho Naing; Joon Wah Mak; Mala Maung; Shew Fung Wong; Ani Izzuani Binti Mohd Kassim
Journal:  Lung       Date:  2012-11-23       Impact factor: 2.584

Review 8.  Diagnosis and treatment of extrapulmonary tuberculosis.

Authors:  Ji Yeon Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-04-02

9.  Exploring the sociodemographic and clinical features of extrapulmonary tuberculosis in Saudi Arabia.

Authors:  Sahal Al-Hajoj; Mohammed Shoukri; Ziad Memish; Raafat AlHakeem; Fahad AlRabiah; Bright Varghese
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

10.  Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study.

Authors:  Georges Reniers; Sylvia Blom; Clara Calvert; Alexandra Martin-Onraet; Abraham J Herbst; Jeffrey W Eaton; Jacob Bor; Emma Slaymaker; Zehang R Li; Samuel J Clark; Till Bärnighausen; Basia Zaba; Victoria Hosegood
Journal:  Lancet HIV       Date:  2016-12-10       Impact factor: 16.070

View more
  3 in total

1.  Child and adult spinal tuberculosis at tertiary hospitals in the Western Cape, South Africa: 4-year burden and trend.

Authors:  T N Mann; H S Schaaf; R N Dunn; S Dix-Peek; K du Preez; R P Lamberts; J du Toit; J H Davis
Journal:  Epidemiol Infect       Date:  2018-09-28       Impact factor: 4.434

2.  Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort.

Authors:  Armon Arpagaus; Fabian Christoph Franzeck; George Sikalengo; Robert Ndege; Dorcas Mnzava; Martin Rohacek; Jerry Hella; Klaus Reither; Manuel Battegay; Tracy Renee Glass; Daniel Henry Paris; Farida Bani; Omary Ngome Rajab; Maja Weisser
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

3.  Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.

Authors:  Doctor B Sibandze; Beki T Magazi; Lesibana A Malinga; Nontuthuko E Maningi; Bong-Akee Shey; Jotam G Pasipanodya; Nontombi N Mbelle
Journal:  BMC Infect Dis       Date:  2020-07-31       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.